Delivery Order SPE2DB22D3301-SPE2DB25FX9TY

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,421.76 and is for the delivery of Rocuronium 50 mg/5 ml vials. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567275952 ROCURONIUM 100 MG/10 ML VIAL 10ML, with a firm fixed price ceiling value of $1,105.56 and a completion date of February 18, 2025. The contract is an open competition with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,174.40 firm fixed-price delivery order is for the supply of 4566581070 ROCURONIUM 100 MG/10 ML VIAL 10ML, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rocuronium 50 mg/5 ml vials, a critical medical supply. The total ceiling value of the contract is $1,421.76, and it has a period of performance through February 19, 2025. This contract award is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,402.97 firm fixed-price delivery order is for the supply of 4564616857 - ROCURONIUM 50 MG/5 ML VIAL 5ML. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 50 mg/5 mL vials of the drug Rocuronium. The contract has a ceiling value of $3,752.99 and an ultimate completion date of December 26, 2024. The contract is not designated as a set-aside procurement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the supply of 4567389512 - ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a ceiling value of $2,837.58 and a completion date of February 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.66 firm fixed-price delivery order is for the supply of 4,566,133,818 units of Rocuronium 50 mg/5 ml vial, a critical medical product used in healthcare settings. The award is not designated with a set-aside and represents an open competition. It is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $1,105.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567367457 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity, to support federal healthcare programs. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order for ROCURONIUM 100 MG/10 ML VIAL 10ML awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,317.12 delivery order is part of a larger indefinite delivery contract between Amerisourcebergen Drug Corp and the DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract does not have a set-aside...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9TY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,600.92, is for the supply of Rocuronium 50 mg/5 ml vials. It is a firm fixed-price contract with a completion date of February 10, 2025. The contract is not designated as a set-aside.

AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/9/25, 10:01 AM